Good morning, everyone. I am Annalisa Ruggeri, hematologist at the San Raffaele Hospital in Milan, and I’m the scientific chair of the next EBMT-EHA European CAR T-cell meeting. And I’m very happy to welcome you to this exciting meeting, which will welcome all experts around the world on CAR T-cell therapy, focusing on clinical and translational aspects...
Good morning, everyone. I am Annalisa Ruggeri, hematologist at the San Raffaele Hospital in Milan, and I’m the scientific chair of the next EBMT-EHA European CAR T-cell meeting. And I’m very happy to welcome you to this exciting meeting, which will welcome all experts around the world on CAR T-cell therapy, focusing on clinical and translational aspects. We will have distinguished speakers from all over the world, and we really believe that this will be a hot topic debate on the main findings on this therapy. We will have an important focus on autoimmune diseases, with the recent experience also in the pediatric setting and the new aspects of application of CAR T-cells in solid tumors.
We really recommend you to register. There is still time to register, also virtually, because this will be a hybrid meeting and the platform will be open then until the 23rd of March. So you can upload and listen and come back to the presentations for over six weeks. And please feel free to contact me and the other organizers if you want to join, and we welcome you in Mallorca next week.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.